Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
William Blair ups EPS to $.35 for PETX in 2019
https://sportsperspectives.com/2017/05/13/william-blair-weighs-in-on-aratana-therapeutics-incs-fy2019-earnings-petx.html
Thanks for the post, loading up more PETX stocks
PETX Broadfin Capital acquires a 10.6% position in PETX in 13G filing
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12059608&RcvdDate=5/11/2017&CoName=ARATANA%20THERAPEUTICS%2C%20INC.&FormType=SC%2013G/A&View=html
LOL he got ya! glta
What is your point? A month in biotechs is an eternity...
Weren't you calling it junk a month ago?
Company announces that it expects to have ENTYCE available in the fall of 2017.
http://ih.advfn.com/p.php?pid=nmona&article=74418092&symbol=PETX
50% loss stock was 10 now its 5, typical garbage overhyped small cap which cannot deliver
Yes, we love our pets so I think this *possibly* could be a fairly good investment, but there are a number of unknowns.. still too early, even with three "approved" products..
biotech_researcher' Thanks for response as usual.
It may be awhile for SP,BUT, people love their pets. At my work we now have pet ins! really! Trump POTUS how would of thunk. gl txs
tste, how do you know that?? Acts like junk..
LOL, BR But, really, why so harsh. This is a good Co. good prospects. gl
Now, officially, a bow-wow stock.... :^)
Chart is very ugly here, barely staying above 5, I say it goes lower. Its very weak and without any near term catalysts what will bring buyers in?
Why retract his statement!? What timeline are you working on? Or are you saying it will never get to 8? Cause he said "eventually"... so...
Mr. Popeye, your quote:
"6.17 was a great place to add or start again. This will eventually get back to 8 and beyond.
Long PETX"
Ready to retract that statement?
Super helpful insight
Can you throw him really far?
Or is that your way of saying you don't value his opinion?
I value Bret Jensen as far as I can throw him..
LOL ! you crack me up. You are everywhere! and I do respect your opinion, very much. I own sgyp rather big. I know going it alone with new product is very scary/would rather not. BUT, new sales force?! Thank you again. lol. GLTY
PS I hope aria again.
SGYP has too many shares outstanding to make it worthwhile. 260 million fully diluted. Plus, if they go it alone, they will have to issue more shares in 12 months..
Nice, I'll take a peek - my other pharma play has been BCRX, since last April or so I believe... just had a rather large run, so may not be the time for entry, but still holding for sure.
Glad you got out in time, me too. I'm going to hold back for a bit of time,too. Looking at sgyp,evok, good luck.
I'm not sure yet, to be honest - I got out of a large chunk of mine during the bloodbath the other day preserving some gains (but a lot less than I had on paper before!)... I still hold a smaller amount so I keep track of daily moves, but I'll probably let it normalize and see if a trend starts up again...
Now, from a longer term buy and hold (which is scary to me on a pharmacy type play) this seems like a decent entry... nothing change really, just got delayed.
So, in short, I'm largely out and not hopping back for a bit.
I'm happy to share when I do add again
Rhew123; You think it's OK to get back in now?. I got out on the positive side. After news/dust settles, I think it's a good entry point again.gl
I believe that they said a good chunk of it was Entyce due to the delay... but that that inventory would still be usable once it can start shipping... as well as Galliprant inventory value adjustment due to market value terms agreed upon with Elanco.
I think they have a bit of a runway on cash... on average spending $14 mil per quarter "operating burn" - that will be a bit higher due to full sales team however - but with $88 million in cash, that's a bit of room...
4th quarter '17 will need to be solid for sure!
So, what was the Q4 $10.7 million inventory write down? And, they are going to have to do a secondary offering before the end of Q3 without a doubt. Dilution.
And they should
Earnings today right? Would love some good news to help keep this climb from the big selloff going.
Under The Radar: Aratana Therapeutics https://goo.gl/Pvs6rp
No harm intended. Just seem to see you around a lot. lol. gl
Paid blogger? Hardly. There is not the volume of messages here on iHub I would think. Twitter might be a platform for that but not for this stock...
You are everywhere! Beginning to wonder!
I am a stupid canuck. Beginning to think you are are a pay'd blogger.
Trying to get filled at 6.25 I might have to raise the bid
I see you on a couple of my sites too funny. I am long, I think petx has a little bit to go till news. glty
Strong finish yesterday. Looking for continued bullish trend, imo. Undervalued here.
I'm lucky I sit at desk all day. Have several screens going.
I'm looking at PETX and OCUL. See which one falls lowest, eod, then buy. GL
There's your dip, good call
Getting a good beating today. I have some $$$ hope it goes lower, then buy. gl
Thanks for reply. I have a little bit money in this stock, was looking for bargain basement, 6.10 , As you mentioned I think it still has a little bit to go till the pop.Best luck.
PS you heard of ocul.
Well considering where PETX was before it fell it's still a dip, lol. The appetite drug that got delayed is still gonna be approved in 2017. Here's the article when it fell.
Shares of Aratana Therapeutics Inc. PETX, +5.26% tumbled 9.1% in premarket trade Monday, after the pet therapeutics company disclosed that the Center for Veterinary Medicine requested more information about its appetite stimulation drug. Aratana said the request is related to the company's post-approval supplement request to transfer the manufacturing of Tentyce to a new vendor. The company said it now expects Entyce to be commercially available by late 2017. The stock has more than doubled over the past 12 months through Friday, while the S&P 500 SPX, +0.36% has gained 22%.
Thanks for post. I was waiting for a dip to buy more. Oh well. GL
From American Bulls.
PETX
NASDAQ ARATANA THERAPEUTICS
Last Signal:BUY
Last Close:+6.60 Change:+0.3300 Percent change+5.26% Signal Update Our system’s recommendation today is to BUY. The pattern finally received a confirmation because the prices crossed above the confirmation level which was at 6.36, and our valid average buying price stands now at 6.37. The previous SELL signal was issued on 02/06/2017, 4 days ago, when the stock price was 7.22. Since then PETX has fallen by -11.80%.Market Outlook Let’s jump on our white horses and go for a bullish ride. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. Most probably, it is the right time to participate in bullish fervor. The market is telling you about a new profit. Do not miss this bullish opportunity.
Followers
|
24
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
438
|
Created
|
08/09/13
|
Type
|
Free
|
Moderators |
Corporate Headquarters
1901 Olathe Blvd
Kansas City, Kansas 66103
(913) 951-2132
Other Locations
200 Clarendon Street; 54th Floor
Boston, Massachusetts 02116
(617) 425-9226
Business Development Contacts
Julia A. Stephanus
Chief Commercial Officer
(913) 951-2139
juliaastephanus@aratana.com
Erick J. Lucera, CPA, CFA
Vice President, Corporate Development
(913) 951-2136
erickjlucera@aratana.com
Investor and Media Contacts
Tiberend Strategic Advisors, Inc.
35 West 35th Street; 11th Floor
New York, New York 10001
(212) 827-0020
Investors - Joshua Drumm, PhD
(212) 375-2665
jdrumm@tiberend.com
Media - Andrew Mielach
(212) 375-2694
amielach@tiberend.com
Transfer Agent and Registrar
American Stock Transfer & Trust Company, LLC.
(800) 937-5449
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |